UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000016904
Receipt No. R000019620
Scientific Title A phase II study of erlotinib plus bevacizumab in chemo-naive patients aged 75 or older with advanced non-squamous non-small-cell lung cancer harboring sensitive EGFR gene mutations(HSR1501)
Date of disclosure of the study information 2015/03/24
Last modified on 2020/08/25 10:24:09

No. Disposal Last modified on Item of update
1 Insert 2015/03/24 22:44:30
2 Update 2016/09/24 07:16:18 Name of primary sponsor
Institute
Department
Organization
Organization
Division
3 Update 2020/08/25 10:13:49 UMIN ID1
4 Update 2020/08/25 10:17:48 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
5 Update 2020/08/25 10:24:09 Recruitment status
Date of IRB
Last follow-up date


Contact us.